Literature DB >> 21823910

Antipsychotic drug administration does not correlate with prolonged rate-corrected QT interval in children and adolescents: results from a nested case-control study.

Christoph U Correll1, Jennifer Harris, Vicki Figen, John M Kane, Peter Manu.   

Abstract

BACKGROUND: The rate-corrected QT interval (QTc) prolongation is a risk factor for sudden cardiac death and may be induced by antipsychotic drugs.
OBJECTIVE: To determine the clinical characteristics associated with QTc prolongation (440 msec or greater) in children and adolescents hospitalized for treatment of psychiatric disorders.
METHOD: We determined the frequency of baseline prolongation of QTc in 811 psychiatric pediatric inpatients (15.5 ± 2.4 years of age). QTc duration was 440 msec or greater (range 441-481 msec) in 16 patients (1.97%). In a 1:5 nested case-control design, the 16 patients with prolonged QTc were age- and gender-matched with 80 patients with QTc of <421 msec.
RESULTS: Patients with normal and prolonged QTc had similar utilization of antipsychotics (43.8% vs. 40.8%) and daily chlorpromazine equivalents (165 ± 110 vs. 168 ± 218 mg). Hypokalemia (p = 0.009) and obesity (p = 0.032) were more common among patients with prolonged QTc. The correlation between obesity and QTc prolongation was confirmed in logistic regression analysis.
CONCLUSIONS: In a large cohort of youth hospitalized for treatment of psychiatric disorders, a prolonged QTc on admission was rare and correlated with the presence of obesity, but not with current use of antipsychotic drugs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21823910      PMCID: PMC3157748          DOI: 10.1089/cap.2011.0024

Source DB:  PubMed          Journal:  J Child Adolesc Psychopharmacol        ISSN: 1044-5463            Impact factor:   2.576


  15 in total

Review 1.  Mechanisms and risks of electrocardiographic QT interval prolongation when using antipsychotic drugs.

Authors:  W Victor R Vieweg
Journal:  J Clin Psychiatry       Date:  2002       Impact factor: 4.384

Review 2.  Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents.

Authors:  T E Wilens; J Biederman; R J Baldessarini; B Geller; D Schleifer; T J Spencer; B Birmaher; A Goldblatt
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-11       Impact factor: 8.829

3.  Increased heterogenity of ventricular repolarization in obese nonhypertensive children.

Authors:  Gerardo Nigro; Vincenzo Russo; Giovanni Di Salvo; Ilaria De Crescenzo; Anna Rago; Laura Perrone; Paolo Golino; Maria Giovanna Russo; Raffaele Calabrò
Journal:  Pacing Clin Electrophysiol       Date:  2010-10-14       Impact factor: 1.976

Review 4.  Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.

Authors:  Peter M Haddad; Ian M Anderson
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 5.  Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly.

Authors:  W Victor R Vieweg; Mark A Wood; Antony Fernandez; Mary Beatty-Brooks; Mehrul Hasnain; Anand K Pandurangi
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

6.  Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.

Authors:  Christoph U Correll; Peter Manu; Vladimir Olshanskiy; Barbara Napolitano; John M Kane; Anil K Malhotra
Journal:  JAMA       Date:  2009-10-28       Impact factor: 56.272

7.  Sex differences in the evolution of the electrocardiographic QT interval with age.

Authors:  P M Rautaharju; S H Zhou; S Wong; H P Calhoun; G S Berenson; R Prineas; A Davignon
Journal:  Can J Cardiol       Date:  1992-09       Impact factor: 5.223

Review 8.  Chlorpromazine equivalent doses for the newer atypical antipsychotics.

Authors:  Scott W Woods
Journal:  J Clin Psychiatry       Date:  2003-06       Impact factor: 4.384

9.  Sudden cardiac death in children and adolescents (excluding Sudden Infant Death Syndrome).

Authors:  Kelly K Gajewski; J Philip Saul
Journal:  Ann Pediatr Cardiol       Date:  2010-07

10.  Association between the corrected QT interval and carotid artery intima-media thickness in obese children.

Authors:  Ayla Güven; Tolga Özgen; Olcay Güngör; Murat Aydın; Kemal Baysal
Journal:  J Clin Res Pediatr Endocrinol       Date:  2010-02-03
View more
  13 in total

1.  Mandatory electrocardiographic monitoring in young patients treated with psychoactive drugs.

Authors:  Renata Rizzo; Mariangela Gulisano; Paola V Calì; Alfredo Di Pino
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-04-04       Impact factor: 4.785

2.  Evaluation of the Safety of Quetiapine in Treating Delirium in Critically Ill Children: A Retrospective Review.

Authors:  Christine Joyce; Robert Witcher; Elizabeth Herrup; Savneet Kaur; Elena Mendez-Rico; Gabrielle Silver; Bruce M Greenwald; Chani Traube
Journal:  J Child Adolesc Psychopharmacol       Date:  2015-10-15       Impact factor: 2.576

3.  Presence or Absence of QTc Prolongation in Buprenorphine-Naloxone Among Youth With Opioid Dependence.

Authors:  Sabrina A Poole; Anna Pecoraro; Geetha Subramaniam; George Woody; Victoria L Vetter
Journal:  J Addict Med       Date:  2016 Jan-Feb       Impact factor: 3.702

4.  Evaluation of monitoring for metabolic effects in children treated with second generation antipsychotics in a pediatric clinic.

Authors:  Brooke L Honey; Lourdes Ramos; Nancy C Brahm
Journal:  J Pediatr Pharmacol Ther       Date:  2013-10

5.  Adverse Effects and Toxicity of the Atypical Antipsychotics: What is Important for the Pediatric Emergency Medicine Practitioner.

Authors:  J J Rasimas; Erica L Liebelt
Journal:  Clin Pediatr Emerg Med       Date:  2012-12-01

Review 6.  Treatment of pediatric migraine in the emergency room.

Authors:  Amy A Gelfand; Peter J Goadsby
Journal:  Pediatr Neurol       Date:  2012-10       Impact factor: 3.372

7.  A cost-effectiveness analysis of off-label atypical antipsychotic treatment in children and adolescents with ADHD who have failed stimulant therapy.

Authors:  Minji Sohn; Jeffery Talbert; Daniela C Moga; Karen Blumenschein
Journal:  Atten Defic Hyperact Disord       Date:  2016-05-03

8.  Evaluation of acute cardiovascular effects of immediate-release methylphenidate in children and adolescents with attention-deficit hyperactivity disorder.

Authors:  Marco Lamberti; Domenico Italiano; Laura Guerriero; Gessica D'Amico; Rosamaria Siracusano; Massimo Ingrassia; Eva Germanò; Maria Pia Calabrò; Edoardo Spina; Antonella Gagliano
Journal:  Neuropsychiatr Dis Treat       Date:  2015-05-08       Impact factor: 2.570

Review 9.  Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approach.

Authors:  Matisyahu Shulman; Avraham Miller; Jason Misher; Aleksey Tentler
Journal:  J Multidiscip Healthc       Date:  2014-10-31

10.  QT is longer in drug-free patients with schizophrenia compared with age-matched healthy subjects.

Authors:  Kumiko Fujii; Yuji Ozeki; Hiroaki Okayasu; Yumiko Takano; Takahiro Shinozaki; Hiroaki Hori; Masami Orui; Minoru Horie; Hiroshi Kunugi; Kazutaka Shimoda
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.